Bitwise Funds Trust has filed a registration statement to delay the effectiveness of its post-effective amendment relating to several PredictionShares until November 29, 2026. This decision is significant as it reflects the company's approach to managing its investment offerings amid fluctuating market conditions.
Bitwise Funds Trust, an investment company based in San Francisco, California, is known for its innovative financial products. The firm is incorporated in Delaware and operates under the Securities Act of 1933 and the Investment Company Act of 1940. Recent filings from the company include multiple 485BXT forms, indicating ongoing adjustments to its investment strategies.
The filing, accession number 0001213900-26-114099, states, "The sole purpose of this filing is to delay the effectiveness of the Registrant’s Post-Effective Amendment No. 53, as it relates to PredictionShares There Will Be A Recession in 2026, PredictionShares There Will Not Be A Recession in 2026, PredictionShares More Tech Layoffs in 2026 Than 2025 and PredictionShares Fewer Tech Layoffs in 2026 Than 2025." This highlights the company's focus on economic predictions and its proactive measures in response to market dynamics.
This delay may impact various stakeholders, including investors and competitors in the investment sector. By postponing the effectiveness of these amendments, Bitwise Funds Trust is likely aiming to reassess and refine its offerings in light of current economic forecasts and investor sentiment.
As for what’s next, the filing does not specify any further actions. However, the delay until November 29, 2026, suggests that the company will continue to monitor market conditions and may provide additional updates as needed.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






